Emerging Insights on Adverse Events During ART and Implications for Treatment

In this comprehensive online program led by expert faculty review clinical strategies for applying the latest safety and tolerability data when selecting or modifying individualized ART regimens for patients with HIV infection.

Share

Program Content

Activities

ART and Weight Gain
Emerging Data on ART-Induced Weight Gain Sheds Light and Raises Questions
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 17, 2021

Expires: June 16, 2022

ART Drug–Drug Interactions
Navigating Polypharmacy and Drug–Drug Interactions in People with HIV
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: January 06, 2022

Expires: January 05, 2023

INSTIs and Metabolic Effects
Weight Gain Associated With INSTIs: What Are the Cardiovascular and Metabolic Implications?
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 05, 2021

Expires: May 04, 2022

Activities

ART and Adverse Events
Emerging Insights on Adverse Events During ART and Implications for Treatment
Congratulations: You achieved a completion on 04/09/2022
Downloadable Slideset
Key Slides on Emerging Insights on Adverse Events During ART and Implications for Treatment
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 11, 2021

Expires: May 10, 2022

Activities

ART Safety Data: Summer 2021
Adverse Events During ART and Implications for Treatment: Key Data From Summer 2021
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: September 22, 2021

Expires: September 21, 2022

Slides: ART AE Data From Summer 2021
Slides: Key Data From Summer 2021
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 22, 2021

Expires: September 21, 2022

ART Safety Data: Fall 2021
Emerging Insights on Adverse Events During ART and Implications for Treatment: Key Data From Fall 2021
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: December 22, 2021

Expires: December 21, 2022

Slides: ART Safety Data: Fall 2021
Emerging Insights on Adverse Events During ART and Implications for Treatment: Key Data From Fall 2021
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 22, 2021

Expires: December 21, 2022

Activities

ART and Adverse Events Part 2
Emerging Insights on Adverse Events During ART and Implications for Treatment: Nephrotoxicity and Long-Acting Injectables
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: November 16, 2021

Expires: November 15, 2022

ART and Adverse Events
Emerging Insights on Adverse Events During ART and Implications for Treatment
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: July 06, 2021

Expires: July 05, 2022

Faculty

cover img faculity

Fidelia Bernice, PharmD

Clinical Pharmacy Specialist, Infectious Diseases
Department of Pharmacy
University of Maryland Medical Center
Baltimore, Maryland

cover img faculity

Eric S. Daar, MD

Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

cover img faculity

Joseph J. Eron, Jr., MD

Professor of Medicine
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

cover img faculity

Gregory Huhn, MD, MPHTM

Interim Chief, Division of Infectious Diseases
Senior Director of HIV Services
Cook County HIV Integrated Programs
Interim Medical Director, The RMR CORE Center
Professor, Division of Infectious Diseases
Rush University Medical Center
Chicago, Illinois

cover img faculity

Aadia I. Rana, MD

Professor of Medicine
Division of Infectious Diseases
University of Alabama at Birmingham Heersink School of Medicine
Birmingham, Alabama

cover img faculity

Darcy Wooten, MD, MS

Professor of Medicine
Division of Infectious Diseases
Washington University
St Louis, Missouri

Provided by

ProCE Banner

Supporters

Educational grant provided by

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare